These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30374002)

  • 1. [Bone and calcium metabolism associated with malignancy. Vitamin D and cancer.].
    Makishima M
    Clin Calcium; 2018; 28(11):1465-1472. PubMed ID: 30374002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Update on recent progress in vitamin D research. Vitamin D receptor and the nuclear receptor superfamily.].
    Makishima M
    Clin Calcium; 2017; 27(11):1533-1541. PubMed ID: 29074825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of Inflammatory Bowel Disease and Colorectal Cancer by Synthetic Vitamin D Receptor Ligands.
    Takada I; Makishima M
    Curr Med Chem; 2017; 24(9):868-875. PubMed ID: 27915991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current Topics on Vitamin D. Nonsecosteroidal vitamin D mudulators and prospects for their thepapeutic application].
    Makishima M
    Clin Calcium; 2015 Mar; 25(3):403-11. PubMed ID: 25716814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
    Boehm MF; Fitzgerald P; Zou A; Elgort MG; Bischoff ED; Mere L; Mais DE; Bissonnette RP; Heyman RA; Nadzan AM; Reichman M; Allegretto EA
    Chem Biol; 1999 May; 6(5):265-75. PubMed ID: 10322128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D receptor modulators for inflammation and cancer.
    Yee YK; Chintalacharuvu SR; Lu J; Nagpal S
    Mini Rev Med Chem; 2005 Aug; 5(8):761-78. PubMed ID: 16101412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-cancer actions of vitamin D.
    Chiang KC; Chen TC
    Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor as a drug discovery target.
    Pinette KV; Yee YK; Amegadzie BY; Nagpal S
    Mini Rev Med Chem; 2003 May; 3(3):193-204. PubMed ID: 12570835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal changes in tissue 1α,25-dihydroxyvitamin D3, vitamin D receptor target genes, and calcium and PTH levels after 1,25(OH)2D3 treatment in mice.
    Chow EC; Quach HP; Vieth R; Pang KS
    Am J Physiol Endocrinol Metab; 2013 May; 304(9):E977-89. PubMed ID: 23482451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1α,25-Dihydroxyvitamin D
    Ishizawa M; Akagi D; Yamamoto J; Makishima M
    J Steroid Biochem Mol Biol; 2017 Sep; 172():55-61. PubMed ID: 28578001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D
    Li M; Li L; Zhang L; Hu W; Shen J; Xiao Z; Wu X; Chan FL; Cho CH
    Life Sci; 2017 Jun; 179():88-97. PubMed ID: 28465245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
    Choi M; Makishima M
    Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D receptor ligands for osteoporosis.
    Cheskis BJ; Freedman LP; Nagpal S
    Curr Opin Investig Drugs; 2006 Oct; 7(10):906-11. PubMed ID: 17086935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia.
    Rovito D; Belorusova AY; Chalhoub S; Rerra AI; Guiot E; Molin A; Linglart A; Rochel N; Laverny G; Metzger D
    Nat Commun; 2020 Dec; 11(1):6249. PubMed ID: 33288743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Update on recent progress in vitamin D research. Development of novel Vitamin D Derivatives.].
    Kagechika H; Fujii S; Tanatani A
    Clin Calcium; 2017; 27(11):1579-1586. PubMed ID: 29074830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Update on recent progress in vitamin D research. Vitamin D and bone, mineral metabolism.].
    Masuyama R
    Clin Calcium; 2017; 27(11):1525-1532. PubMed ID: 29074824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rickets/Osteomalacia. The function and mechanism of vitamin D action.].
    Makishima M
    Clin Calcium; 2018; 28(10):1319-1326. PubMed ID: 30269113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.